Lexicon Pharma (LXRX) reported Q1 Revenue
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.55 +11.35%
Revenue Growth %: -86.1%
Financial Fact:
Interest expense: -1.65M
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: -86.1%
Financial Fact:
Interest expense: -1.65M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q1 Revenue for the quarter came in at $21.1 million versus the consensus estimate of $9.78 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gulfport Energy and Mobility Global to join S&P SmallCap 600
- TNL Mediagene faces Nasdaq delisting over bid price and equity rules
- AES stockholders approve $10.7 billion takeover by GIP and EQT
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
